-
1
-
-
0032773188
-
Single-agent docetaxel (Taxotere) in randomized phase III trials
-
Burris III HA (1999) Single-agent docetaxel (Taxotere) in randomized phase III trials. Semin Oncol 26: 1-6
-
(1999)
Semin Oncol
, vol.26
, pp. 1-6
-
-
Burris III, H.A.1
-
2
-
-
0018576207
-
Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5′-deoxy-5-fluoropyrimidine nucleosides
-
Cook AF, Holman MJ, Kramer MJ, Trown PW (1979) Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5′-deoxy-5-fluoropyrimidine nucleosides. J Med Chem 22: 1330-1335
-
(1979)
J Med Chem
, vol.22
, pp. 1330-1335
-
-
Cook, A.F.1
Holman, M.J.2
Kramer, M.J.3
Trown, P.W.4
-
3
-
-
0030884186
-
Efficacy of combination chemotherapy of cyclophosphamide and 5′-deoxy-5-fluorouridine in a mammary tumor xenograft model, MX-1
-
Japanese
-
Endo M, Fujimoto-Ouchi K, Matsumoto T, Tanaka Y, Ishitsuka H (1997) Efficacy of combination chemotherapy of cyclophosphamide and 5′-deoxy-5-fluorouridine in a mammary tumor xenograft model, MX-1. Jpn J Cancer Chemother 24: 1295-1301, (Japanese)
-
(1997)
Jpn J Cancer Chemother
, vol.24
, pp. 1295-1301
-
-
Endo, M.1
Fujimoto-Ouchi, K.2
Matsumoto, T.3
Tanaka, Y.4
Ishitsuka, H.5
-
4
-
-
0032856558
-
Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5′-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models
-
Endo M, Shinbori N, Fukase Y, Sawada N, Ishikawa T, Ishitsuka H, Tanaka Y (1999) Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5′-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models. Int J Cancer 83: 127-134
-
(1999)
Int J Cancer
, vol.83
, pp. 127-134
-
-
Endo, M.1
Shinbori, N.2
Fukase, Y.3
Sawada, N.4
Ishikawa, T.5
Ishitsuka, H.6
Tanaka, Y.7
-
5
-
-
0027125627
-
Angiogenic factor
-
Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Yamada Y (1992) Angiogenic factor. Nature 356: 668
-
(1992)
Nature
, vol.356
, pp. 668
-
-
Furukawa, T.1
Yoshimura, A.2
Sumizawa, T.3
Haraguchi, M.4
Akiyama, S.5
Fukui, K.6
Ishizawa, M.7
Yamada, Y.8
-
6
-
-
0029789811
-
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
-
Greenberg PA, Hortobagyi GN, Smith TL, Zeigler LD, Frye DK, Buzdar AU (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14: 2197-2205
-
(1996)
J Clin Oncol
, vol.14
, pp. 2197-2205
-
-
Greenberg, P.A.1
Hortobagyi, G.N.2
Smith, T.L.3
Zeigler, L.D.4
Frye, D.K.5
Buzdar, A.U.6
-
7
-
-
0002096952
-
Breast Cancer
-
DeVita Jr VT, Hellman S, Rosenberg SA (eds) Philadelphia: Lippincott
-
Henderson IC, Harris JR, Kinne DW, Hellman S (1989) Breast Cancer. In Cancer: Principles and Practice of Oncology DeVita Jr VT, Hellman S, Rosenberg SA (eds) pp 1197-1268. Philadelphia: Lippincott
-
(1989)
Cancer: Principles and Practice of Oncology
, pp. 1197-1268
-
-
Henderson, I.C.1
Harris, J.R.2
Kinne, D.W.3
Hellman, S.4
-
8
-
-
0029037859
-
Selective inhibition of spontaneous pulmonary metastasis of Lewis lung carcinoma by 5′-deoxy-5-fluorouridine
-
Ishikawa T, Ura M, Yamamoto T, Tanaka Y, Ishitsuka H (1995) Selective inhibition of spontaneous pulmonary metastasis of Lewis lung carcinoma by 5′-deoxy-5-fluorouridine. Int J Cancer 61: 516-521
-
(1995)
Int J Cancer
, vol.61
, pp. 516-521
-
-
Ishikawa, T.1
Ura, M.2
Yamamoto, T.3
Tanaka, Y.4
Ishitsuka, H.5
-
9
-
-
0018821981
-
Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine
-
Japanese
-
Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A, Maruyama HB (1980) Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5- fluorouridine. GANN 71: 112-123, (Japanese)
-
(1980)
GANN
, vol.71
, pp. 112-123
-
-
Ishitsuka, H.1
Miwa, M.2
Takemoto, K.3
Fukuoka, K.4
Itoga, A.5
Maruyama, H.B.6
-
10
-
-
0033770113
-
Capecitabine: Preclinical pharmacology studies
-
Ishitsuka H (2000) Capecitabine: preclinical pharmacology studies. Invest New Drugs 18: 343-354
-
(2000)
Invest New Drugs
, vol.18
, pp. 343-354
-
-
Ishitsuka, H.1
-
11
-
-
0020530463
-
Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors
-
Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y, Ishitsuka H (1983) Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull 31: 175-178
-
(1983)
Chem Pharm Bull
, vol.31
, pp. 175-178
-
-
Kono, A.1
Hara, Y.2
Sugata, S.3
Karube, Y.4
Matsushima, Y.5
Ishitsuka, H.6
-
12
-
-
0032127244
-
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
-
Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I, Ishitsuka H (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34: 1274-1281
-
(1998)
Eur J Cancer
, vol.34
, pp. 1274-1281
-
-
Miwa, M.1
Ura, M.2
Nishida, M.3
Sawada, N.4
Ishikawa, T.5
Mori, K.6
Shimma, N.7
Umeda, I.8
Ishitsuka, H.9
-
13
-
-
0003557921
-
-
Berlin, Heidelberg, New York, London, Paris, Tokyo: UICC, Springer-Verlag
-
Monfardini S, Brunner K, Crowther D, Eckhardt S, Olive D, Tanneberger S, Veronesi A, Whitehouse J, Wittes R (1987) Manual of Adult and Pediatric Medical Oncology pp 22-38. Berlin, Heidelberg, New York, London, Paris, Tokyo: UICC, Springer-Verlag
-
(1987)
Manual of Adult and Pediatric Medical Oncology
, pp. 22-38
-
-
Monfardini, S.1
Brunner, K.2
Crowther, D.3
Eckhardt, S.4
Olive, D.5
Tanneberger, S.6
Veronesi, A.7
Whitehouse, J.8
Wittes, R.9
-
14
-
-
0033006075
-
The academic global virtual concept in clinical cancer research and its application o breast cancer: The Breast Cancer International Research Group
-
Nabholtz JM, Lindsay MA, Hugh J, Mackey J, Smylie M, Au HJ, Tonkin K, Allen M (1999) The academic global virtual concept in clinical cancer research and its application o breast cancer: The Breast Cancer International Research Group. Semin Oncol 26: 4-8
-
(1999)
Semin Oncol
, vol.26
, pp. 4-8
-
-
Nabholtz, J.M.1
Lindsay, M.A.2
Hugh, J.3
Mackey, J.4
Smylie, M.5
Au, H.J.6
Tonkin, K.7
Allen, M.8
-
15
-
-
0022302891
-
Phase II study of 5′-deoxy-5-fluorouridine (5′-DFUR) in patients with malignant cancer - A multi-institutional cooperative study
-
Japanese
-
Niitani H, Kimura K, Saito T, Nakao I, Abe O, Urshizaki I, Ohta K, Yoshida Y, Kimura T, Kurihara M, Takeda C, Taguchi T, Terasawa T, Tominaga K, Furue H, Wakui A, Ogawa N (1985) Phase II study of 5′-deoxy-5- fluorouridine (5′-DFUR) in patients with malignant cancer - a multi-institutional cooperative study. Gan To Kagaku Ryoho 12: 2044-2051, (Japanese)
-
(1985)
Gan to Kagaku Ryoho
, vol.12
, pp. 2044-2051
-
-
Niitani, H.1
Kimura, K.2
Saito, T.3
Nakao, I.4
Abe, O.5
Urshizaki, I.6
Ohta, K.7
Yoshida, Y.8
Kimura, T.9
Kurihara, M.10
Takeda, C.11
Taguchi, T.12
Terasawa, T.13
Tominaga, K.14
Furue, H.15
Wakui, A.16
Ogawa, N.17
-
16
-
-
0029806438
-
Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues
-
Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H (1996) Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407-1411
-
(1996)
Biol Pharm Bull
, vol.19
, pp. 1407-1411
-
-
Nishida, M.1
Hino, A.2
Mori, K.3
Matsumoto, T.4
Yoshikubo, T.5
Ishitsuka, H.6
-
17
-
-
0037096755
-
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results
-
O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub J-P, Cervantes G, Fumoleau P, Jones S, Lui W-Y, Mauriac L, Twelves C, Hazel GV, Verma S, Leonard R (2002) Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 20: 2812-2823
-
(2002)
J Clin Oncol
, vol.20
, pp. 2812-2823
-
-
O'Shaughnessy, J.1
Miles, D.2
Vukelja, S.3
Moiseyenko, V.4
Ayoub, J.-P.5
Cervantes, G.6
Fumoleau, P.7
Jones, S.8
Lui, W.-Y.9
Mauriac, L.10
Twelves, C.11
Hazel, G.V.12
Verma, S.13
Leonard, R.14
-
18
-
-
0026722646
-
Combination therapy of doxifluridine (5′-DFUR) + cyclophosphamide(CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer
-
Ohta J, Taguchi T, Sakai K (1992) Combination therapy of doxifluridine (5′-DFUR) + cyclophosphamide(CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Jpn J Cancer Chemother 19: 1279-1284
-
(1992)
Jpn J Cancer Chemother
, vol.19
, pp. 1279-1284
-
-
Ohta, J.1
Taguchi, T.2
Sakai, K.3
-
19
-
-
0018832138
-
Comparative studies on the immunosuppressive effect among 5′-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil
-
Japanese
-
Ohta Y, Sueki K, Kitta K, Takemoto K, Ishituka H, Yagi Y (1980) Comparative studies on the immunosuppressive effect among 5′-deoxy-5- fluorouridine, ftorafur, and 5-fluorouracil. GANN 71: 190-196, (Japanese)
-
(1980)
GANN
, vol.71
, pp. 190-196
-
-
Ohta, Y.1
Sueki, K.2
Kitta, K.3
Takemoto, K.4
Ishituka, H.5
Yagi, Y.6
-
20
-
-
0032894654
-
Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy
-
Rahman ZU, Frye DK, Smith TL, Asmar L, Theriault RL, Buzdar AU, Hortobagyi GN (1999) Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy. Cancer 85: 104-111
-
(1999)
Cancer
, vol.85
, pp. 104-111
-
-
Rahman, Z.U.1
Frye, D.K.2
Smith, T.L.3
Asmar, L.4
Theriault, R.L.5
Buzdar, A.U.6
Hortobagyi, G.N.7
-
21
-
-
0031944611
-
Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by Taxol/Taxotere in human cancer xenografts
-
Sawada N, Ishikawa T, Fukase Y, Nishida M, Yoshikubo T, Ishitsuka H (1998) Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by Taxol/Taxotere in human cancer xenografts. Clin Cancer Res 4: 1013-1019
-
(1998)
Clin Cancer Res
, vol.4
, pp. 1013-1019
-
-
Sawada, N.1
Ishikawa, T.2
Fukase, Y.3
Nishida, M.4
Yoshikubo, T.5
Ishitsuka, H.6
-
22
-
-
0029790295
-
Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma
-
Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T (1996) Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1110-1117
-
-
Takebayashi, Y.1
Akiyama, S.2
Akiba, S.3
Yamada, K.4
Miyadera, K.5
Sumizawa, T.6
Yamada, Y.7
Murata, F.8
Aikou, T.9
-
23
-
-
0025335797
-
Anticachetic activity of 5′-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma
-
Tanaka Y, Eda H, Fujimoto K, Tanaka T, Ishikawa T, Ishitsuka H (1990) Anticachetic activity of 5′-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma. Cancer Res 50: 4528-4532
-
(1990)
Cancer Res
, vol.50
, pp. 4528-4532
-
-
Tanaka, Y.1
Eda, H.2
Fujimoto, K.3
Tanaka, T.4
Ishikawa, T.5
Ishitsuka, H.6
-
24
-
-
0037445121
-
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with mode-positive breast cancer after primary surgery
-
Tominaga T, Koyama H, Toge T, Miura S, Sugimachi K, Yamaguchi S, Hirata H, Monden Y, Nomura Y, Toi M, Kimijima I, Noguchi S, Sonoo H, Asaishi K, Ikeda T, Morimoto T, Ota J, Ohashi Y, Abe O (2003) Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with mode-positive breast cancer after primary surgery. J Clin Oncol 15: 991-998
-
(2003)
J Clin Oncol
, vol.15
, pp. 991-998
-
-
Tominaga, T.1
Koyama, H.2
Toge, T.3
Miura, S.4
Sugimachi, K.5
Yamaguchi, S.6
Hirata, H.7
Monden, Y.8
Nomura, Y.9
Toi, M.10
Kimijima, I.11
Noguchi, S.12
Sonoo, H.13
Asaishi, K.14
Ikeda, T.15
Morimoto, T.16
Ota, J.17
Ohashi, Y.18
Abe, O.19
-
25
-
-
0022396847
-
The therapeutic effects of orally administered 5′-deoxy-5- fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors
-
Uehara N, Baba H, Nitta K, Kunimoto T, Takeuchi M, Sasaki T, Tanaka T (1985) The therapeutic effects of orally administered 5′-deoxy-5- fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors. Jpn J Cancer Res 76: 1034-1041
-
(1985)
Jpn J Cancer Res
, vol.76
, pp. 1034-1041
-
-
Uehara, N.1
Baba, H.2
Nitta, K.3
Kunimoto, T.4
Takeuchi, M.5
Sasaki, T.6
Tanaka, T.7
-
26
-
-
0345507721
-
Treatment of metastatic breast cancer using a combination of two oral drugs of 5′-deoxy-5-fluorouridine and cyclophosphamide
-
Japanese
-
Yoshimoto M, Tada T, Saito M, Takahashi K, Kasumi F (1998) Treatment of metastatic breast cancer using a combination of two oral drugs of 5′-deoxy-5-fluorouridine and cyclophosphamide. J Clin Exp Med (Igaku No Ayumi) 184: 1013-1014, (Japanese)
-
(1998)
J Clin Exp Med (Igaku No Ayumi)
, vol.184
, pp. 1013-1014
-
-
Yoshimoto, M.1
Tada, T.2
Saito, M.3
Takahashi, K.4
Kasumi, F.5
|